Alopecia areata is a chronic autoimmune hair loss disorder characterized by immune-mediated attack of hair follicles, resulting in patchy hair loss and variable disease progression. The disease shows significant heterogeneity in onset, severity, and treatment response. Biomarker-driven approaches provide insights into immune activity, follicular dysfunction, and underlying disease mechanisms.

Nordic Bioscience’s ProteinFingerPrint Technology™ offers a clinically validated, ECM-focused biomarker platform that enables precise disease characterization, supports targeted therapy development, and facilitates scalable diagnostic solutions. This approach enhances precision medicine by identifying distinct pathological processes and guiding effective, individualized treatment strategies.

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease characterized by painful nodules, abscesses, and sinus tract formation, leading to significant tissue remodeling and scarring. The disease shows marked clinical heterogeneity and is associated with systemic inflammation, making accurate assessment of disease activity and progression challenges. Tissue-specific biomarkers may provide objective insights into disease activity, ongoing inflammation, and tissue destruction.

Nordic Bioscience’s ProteinFingerPrint Technology™ is a clinically validated, ECM-focused biomarker platform designed to support detailed disease characterization and the development of targeted therapies. By capturing key pathological processes involved in inflammation and tissue remodeling, this approach may support improved patient stratification and contribute to more individualized treatment strategies in HS.

Scleroderma (Systemic sclerosis) is a chronic autoimmune connective tissue disease characterized by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. The disease shows significant heterogeneity in clinical presentation, organ involvement, and disease progression. Biomarker-driven approaches provide insights into immune activity, fibrotic processes, and underlying disease mechanisms.

Nordic Bioscience’s ProteinFingerPrint Technology™ offers a clinically validated, ECM-focused biomarker platform that enables precise disease characterization, supports targeted therapy development, and facilitates scalable diagnostic solutions. This approach enhances precision medicine by identifying distinct pathological processes and guiding effective, individualized treatment strategies.

Urticaria is a chronic inflammatory skin disorder characterized by recurrent episodes of wheals and/or angioedema, driven by immune activation and mast cell-mediated responses. The disease shows significant heterogeneity in clinical presentation, severity, and treatment response. Biomarker-driven approaches provide insights into immune pathways, inflammatory activity, and underlying disease mechanisms.

Nordic Bioscience’s ProteinFingerPrint Technology™ offers a clinically validated, ECM-focused biomarker platform that enables precise disease characterization, supports targeted therapy development, and facilitates scalable diagnostic solutions. This approach enhances precision medicine by identifying distinct pathological processes and guiding effective, individualized treatment strategies.